Anticoagulation options for intermittent haemodialysis

Minerva Urologica e Nefrologica

Volumn 58, Issue 2, 2006, Pages 171-180

  Davenport, A ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Argatroban; Citrate; Danaparoid; Heparins; HIT; Nafamostat hirudin; Prostacyclin

Indexed keywords

ANTITHROMBIN; ARDEPARIN; ARGATROBAN; CITRIC ACID; DALTEPARIN; DANAPAROID; DEFIBROTIDE; ENOXAPARIN; FONDAPARINUX; HEPARIN; HEPARINOID; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NAFAMSTAT; PARNAPARIN; PROSTACYCLIN; PROSTANOID; REVIPARIN; THROMBIN INHIBITOR; TINZAPARIN; XIMELAGATRAN;

AGRANULOCYTOSIS; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTHRALGIA; BLEEDING; DRUG ACTIVITY; DRUG HALF LIFE; EOSINOPHILIA; HEMODIALYSIS; HUMAN; HYPERKALEMIA; MYALGIA; OSTEOPOROSIS; REVIEW; THROMBOCYTOPENIA;

ANTICOAGULANTS; HEPARIN; HUMANS; RENAL DIALYSIS; THROMBOSIS;

EID: 33745500449     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Fagette P. Hemodialysis 1912-1945: no medical technology before its time part I. ASAIO J 1999;45:238-49.
2. Fagette P. Hemodialysis 1912-1945: no medical technology before its time part II. ASAIO J 1999;45:379-91.
3. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M. Continuous venovenous hemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic system, coagulation pathways. Intensive Care Med 1997;23:38-43.
4. Zimmerman GA, Guy A. Two by two: the pairings of P selectinand P selectin glycoprotein. Proc Natl Acad Sci 2001;98:10023-24.
5. Hugel B, Martinez MC, Kunzelmann C, Freysinet JM. Membrane microparticles. Two sides of the same coin. Physiology 2005;20:22-7.
6. European Dialysis and Transplant Association. Best practice guidelines for haemodialysis. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporeal circuit. Nephrol Dial Transplant 2002;17 Suppl 7:563-7.
7. Davenport A. Sudden onset of adult respiratory distress syndrome (ARDS) in a long standing chronic haemodialysis patient with lung calcification. Nephrol Dialysis Transplant 2006;21:807-10.
8. Warkentin E. New approaches to the diagnosis of heparin induced thrombocytopenia. Chest 2005;127:35S-45S.
9. Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R. Antithrombin III supplementation reduces heparin requirement and platelet loss during haemodialysis of patients with fulminant hepatic failure. Hepatoly 1991;14:251-6.
10. Stiekema JC, Van Griensen JM, Van Dinther TG, Cohen AF. A cross over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuron. Br J Clin Pharmacol 1993;36:51-6.
11. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999;56:1578-83.
12. Leitienne P, Fouque D, Rigal D, Adeleine P, Trzeciak MC, Laville M. Heparins and blood polymorphonuclear stimulation in hemodialysis: an expansion of the biocompatibility concept. Nephrol Dial Transplant 2000;15:1631-7.
13. Lai KN, Ho K, Cheung RC, Lit LC, Lee SK, Fung KS et al. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Int J Artif Organs 2001;24:447-55.
14. Lee KB, Kim B, Lee YH, Yoon SJ, Kang WH, Huh W et al. Haemodialysis using heparin bound hemophan in patients at risk of bleeding. Nephron Clin Pract 2004;97:c5-c10.
15. Dario-Frank R, Muller U, Lanzmich R, Groeger C, Floege J. Anticoagulatiant free Genius haemodialysis using low molecular weight heparin coated circuits. Nephrol Dial Transplant 2006;21:1013-8.
16. Davenport A. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy. Am J Kid Dis 1998;32:E3.
17. Davenport A. The management of Heparin induced thrombocytopenia during renal replacement therapy. Hemodial Int 2001;5:81-5.
18. Apsner R, Buchmayer H, Lang T, Unver B, Speiser W, Sunder-Plassmann G et al. Simplified citrate anticoagulation for high flux hemodialysis. Am J Kid Dis 2001;38:979-87.
19. Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS. Regional hemodialysis anticoagulation: Hypertonic trisodium citrate or anticoagulation citrate dextrose-A. Am J Kid Dis 1996;27:519-24.
20. Evenepoel P, Maes B, Vanwalleghem J, Kuypers D, Messiaen T, Vanrenterghem Y. Regional citrate anticoagulation for haemodialysis using a conventional calcium containing dialysate. Am J Kid Dis 2002;39:315-23
21. Davenport A. Problems with anticoagulation. In: Lameire N, Mehta R editors. Complications of dialysis: recognition and management. Boston: Marcel Dekker; 1999. p. 215-40.
22. Davenport A. Anticoagulation in patients with acute renal failure treated with continuous renal replacement therapies. Home Hemodial Int 1998;2:41-60.
23. Fischer KG, Loo van de A, Bohler J. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Kidney Int 1999;72 Suppl:S46-50.
24. Eichler P, Friesen HJ, Lubenow N, Jaeger B, Greinacher A. Antihirudin antibodies in patients with heparin induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood 2000;96:2373-8.
25. Hafner G, Roser M, Nauck M. Methods for the monitoring of direct thrombin inhibitors. Semin Thromb Haemostat 2002;28:425-30.
26. Fenyvesi T, Harenberg J, Weiss C, Jörg I. Comparison of two different ecarin clotting time methods. J Thrombosis Thrombolysis 2005;20:51-6.
27. Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J et al. A prospective comparison of three argatroban treatment regimens during haemodialysis in end stage renal failure. Kid Int 2004;66:2446-53.
28. Akizawa T. Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation. Rinsho Ketsueki 1990;31:782-6. Japanese.0
29. Matsuo T, Kario K, Nakao K, Yamada T, Matsuo M. Anticoagulation with nafamostat mesilate, a synthetic protease inibitor, in hemodialysis patients with a bleeding risk. Haemostatasis 1993;23:135-41.
30. Filimberti E, Cinotti S, Salvadori M, Amato M, Longo G, Nazzar M et al. Hemodialysis with Defibrotide: effects on coagulation parameters. Int J Artif Organs 1992;15:590-4.
31. Davenport A. Heparin induced thrombocytopenia during renal replacement therapy. Haemodial Int 2004;8:295-303.